NRNP 6675 (PMHNP Care Across the Lifespan II) is an advanced course in the Walden University Psychiatric Mental Health Nurse Practitioner program. The course builds on NRNP 6665 and covers complex psychiatric disorders, advanced psychopharmacology, and comprehensive treatment planning for patients across all age groups from children to older adults.
The major content areas in NRNP 6675 include complex mood disorders including bipolar disorder and treatment-resistant depression, schizophrenia spectrum disorders and antipsychotic management, personality disorders and evidence-based psychotherapy approaches, substance use disorders and dual diagnosis treatment, neurodevelopmental disorders in children and adolescents, and psychiatric care for older adults including dementia and late-life depression.
Advanced psychopharmacology is central to NRNP 6675. You must know mood stabilizers including lithium, valproate, and lamotrigine with their monitoring parameters. Antipsychotic medications including both first and second generation agents, their mechanisms, side effects, and metabolic monitoring requirements are heavily tested. Antidepressants, anxiolytics, and stimulants for ADHD are also important.
Start reviewing four weeks before the final exam. Create a medication chart organizing psychiatric drugs by class with their key features, monitoring requirements, and contraindications. Review DSM-5 diagnostic criteria for major psychiatric disorders. Practice applying treatment algorithms to clinical case vignettes similar to those used in the exam.
Many students lose points by not reading questions carefully enough. NRNP 6675 questions often include clinical nuances that change the correct answer. Pay attention to patient age, pregnancy status, medical comorbidities, and medication history as these factors frequently determine the most appropriate psychiatric treatment approach.